Literature DB >> 10870175

Hepatitis A in patients with chronic liver disease - severity of illness and prevention with vaccination.

E Keeffe1.   

Abstract

Acute hepatitis A in patients with pre-existing chronic liver disease (CLD) may theoretically predispose such patients to a more severe outcome of infection. The results of reports covering epidemics and case series suggest but do not universally support this possibility. An analysis of the larger case series support the suggestion that acute hepatitis A superimposed on chronic hepatitis B infection is associated with higher peak laboratory abnormalities, more severe disease and a higher fatality rate. The safety and immunogenicity of an inactivated hepatitis A vaccination was evaluated in patients with CLD and found to be satisfactory for the protection of this group of patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10870175     DOI: 10.1046/j.1365-2893.2000.00016.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  5 in total

1.  Long-term durability of immune responses after hepatitis A vaccination among HIV-infected adults.

Authors:  Nancy F Crum-Cianflone; Kenneth Wilkins; Andrew W Lee; Anthony Grosso; Michael L Landrum; Amy Weintrob; Anuradha Ganesan; Jason Maguire; Stephanie Klopfer; Carolyn Brandt; William P Bradley; Mark R Wallace; Brian K Agan
Journal:  J Infect Dis       Date:  2011-06-15       Impact factor: 5.226

Review 2.  Vaccinations for adult solid-organ transplant recipients: current recommendations and protocols.

Authors:  Andrea Duchini; John A Goss; Saul Karpen; Paul J Pockros
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

3.  Prevention of Hepatitis A Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2020.

Authors:  Noele P Nelson; Mark K Weng; Megan G Hofmeister; Kelly L Moore; Mona Doshani; Saleem Kamili; Alaya Koneru; Penina Haber; Liesl Hagan; José R Romero; Sarah Schillie; Aaron M Harris
Journal:  MMWR Recomm Rep       Date:  2020-07-03

Review 4.  Screening of donor and recipient prior to solid organ transplantation.

Authors: 
Journal:  Am J Transplant       Date:  2004-11       Impact factor: 8.086

Review 5.  Molecular biology and inhibitors of hepatitis A virus.

Authors:  Yannick Debing; Johan Neyts; Hendrik Jan Thibaut
Journal:  Med Res Rev       Date:  2013-05-30       Impact factor: 12.944

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.